Tevogen Bio Holdings Inc.TVGNNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank67
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Percentile
P67
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2024-11.62+64.6%
2023-32.84-111.4%
2022289.02+979.1%
2021-32.88-